Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Pyostomatitis Vegetans Associated with Inflammatory Bowel Disease : Report of Two Cases (CROSBI ID 168285)

Prilog u časopisu | stručni rad

Mijandrušić Sinčić, Brankica ; Licul, Vanja ; Gorup, Lari ; Brnčić, Nada ; Glažar, Irena ; Lučin, Ksenija Pyostomatitis Vegetans Associated with Inflammatory Bowel Disease : Report of Two Cases // Collegium antropologicum, 34 (2010), S2; 279-282

Podaci o odgovornosti

Mijandrušić Sinčić, Brankica ; Licul, Vanja ; Gorup, Lari ; Brnčić, Nada ; Glažar, Irena ; Lučin, Ksenija

engleski

Pyostomatitis Vegetans Associated with Inflammatory Bowel Disease : Report of Two Cases

Pyostomatitis vegetans (PV) is a rare, chronic mucocutaneous disorder associated with inflammatory bowel disease (IBD). Oral lesions of PV are distinct and present as multiple white or yellow pustules with an erythematous base that coalesce and undergo necrosis to form a typical "snail tracks" appearance. Two cases of PV associated with IBD - one with Crohn's disease (CD) and the other with ulcerative colitis (UC) are reported. In the first case, adalimumab therapy brought the oral and gastrointestinal manifestations to complete remission. In the second case, the remission was achieved with systemic steroid therapy, but the disease relapsed after therapy discontinuation. Azathioprine was added leading to sustained remission of PV Because of persistent active intestinal manifestation of UC, in spite of immunosuppressive therapy, infliximab was introduced. With the therapy remission of intestinal manifestation of UC was achieved as well. Our cases confirm previously reported good experience with immunomodulators and biologics in the treatment of PV. But, before using them we have to exclude an infectious etiology of oral lesions.

pyostomatitis vegetans; inflammatory bowel disease; corticosteroids; azathioprine; adalimumab; infliximab

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

34 (S2)

2010.

279-282

objavljeno

0350-6134

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost